Sinocare presents chronic disease management solutions at EASD congress
Sinocare is showcasing its integrated chronic disease management solutions at the EASD 2026 congress in Milan. The portfolio includes devices for home, pharmacy, and hospital settings.
Chinese health technology company Sinocare presented its integrated solutions for chronic disease management at the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD 2026) in Milan, held from September 28 to October 2, 2026. The company's presented product portfolio covers various care settings, including home use, pharmacies, and hospitals, offering solutions from risk detection and daily monitoring to clinical diagnostics and patient care.
For home use, Sinocare featured the Safe AQ max II Blood Glucose Monitoring System, which provides results in five seconds and supports data synchronization via Bluetooth. Additionally, the KUG-11 meter was presented, capable of performing three metabolic analyses (glucose, uric acid, and ketones) in a single device, alongside the GV-100 system for home diabetes management in pets like dogs and cats.
For pharmacies, the iCARE-1300 Portable Automatic Multifunction Analyzer can automatically perform analyses for nearly 100 parameters, including blood glucose, lipid profiles, HbA1c, and kidney function, delivering results within approximately 3 to 15 minutes. Through its "Health Station" model, Sinocare also assists pharmacies in strengthening their capacity for chronic disease screening and risk assessment.
Hospital solutions include the AGEscan device, which offers non-invasive detection of Advanced Glycation End products (AGEs) without blood sampling, facilitating early risk identification. The Safe AQ 8000 Hospital Blood Glucose Smart Management System connects to hospital information systems (HIS) and integrates data from glucometers and continuous glucose monitoring (CGM) systems via a Doctor Web portal, simplifying bedside measurements and patient monitoring.
Founded in 2002, Sinocare is a leading Chinese company in blood glucose meters and one of the country's largest manufacturers of blood glucose monitoring devices. With over 780 patents, the company aims to develop more accessible and interconnected chronic disease management solutions globally.